Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2026-01-20 @ 8:44 AM
Study NCT ID:
NCT02846766
Status:
WITHDRAWN
Last Update Posted:
2018-08-02
First Post:
2016-05-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
Sponsor:
Teresa Helsten, MD
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-07-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2020-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2016-05-12
First Submit QC Date:
None
Study First Post Date:
2016-07-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-07-31
Last Update Post Date:
2018-08-02
Last Update Post Date Type:
ACTUAL